BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6300971)

  • 1. A comparison of the inhibitory effects of prostacyclin and carbacyclin on platelet adhesion to collagen.
    Karniguian A; Simmons P; Legrand YJ; Moncada S; Caen JP
    Prostaglandins; 1982 Dec; 24(6):827-36. PubMed ID: 6300971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prostacyclin analogue (carbacyclin) on the interaction of platelets with different collagen substrates. Inhibition of cAMP increase by collagens type I, III, and IV.
    Mazurov AV; Misselwitz F; Hoffman U; Leytin VL; Repin VS
    Prostaglandins; 1988 Jan; 35(1):51-65. PubMed ID: 2836888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
    Whittle BJ; Moncada S; Whiting F; Vane JR
    Prostaglandins; 1980 Apr; 19(4):605-27. PubMed ID: 6992234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
    O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S
    Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
    Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
    Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin).
    Aiken JW; Shebuski RJ
    Prostaglandins; 1980 Apr; 19(4):629-43. PubMed ID: 6992235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a collagen derived octapeptide on different steps of the platelet/collagen interaction.
    Karniguian A; Legrand YJ; Lefrancier P; Caen JP
    Thromb Res; 1983 Dec; 32(6):593-604. PubMed ID: 6320490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandins: specific inhibition of platelet adhesion to collagen and relationship with cAMP level.
    Karniguian A; Legrand YJ; Caen JP
    Prostaglandins; 1982 Apr; 23(4):437-57. PubMed ID: 6287536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of ZK 36374, a stable prostacyclin analogue, on adhesion of rabbit platelets to damaged aorta and serotonin release by adherent platelets.
    Menys VC; Davies JA
    Clin Sci (Lond); 1983 Aug; 65(2):149-53. PubMed ID: 6190604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A scanning electron microscopic investigation of effects of prostacyclin on platelet retention in glass bead columns.
    Ts'ao C; Krajewski D; Ng A
    Scand J Haematol; 1982 Jan; 28(1):23-31. PubMed ID: 7041243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of PGI2 and PGI2 analogues with increased stability on platelet cAMP content and aggregation.
    Blaskó G; Nemesánszky E; Szabó G; Stadler I; Pálos LA
    Thromb Res; 1980 Mar; 17(5):673-81. PubMed ID: 6247777
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of carbacyclin, a prostaglandin analogue, on adenylate cyclase activity in platelet membranes.
    Stein JM; Martin BR
    FEBS Lett; 1984 Jan; 165(2):290-2. PubMed ID: 6363123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostaglandin I2 on platelet adhesion.
    Fésüs L; Hársfalvi J; Kovács E; Muszbek L; Stadler I
    Biomaterials; 1981 Jan; 2(1):53-4. PubMed ID: 7016206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prostacyclin analogue carbacyclin inhibits Ca(2+)-activated K+ current in aortic baroreceptor neurones of rats.
    Li Z; Lee HC; Bielefeldt K; Chapleau MW; Abboud FM
    J Physiol; 1997 Jun; 501 ( Pt 2)(Pt 2):275-87. PubMed ID: 9192300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies of thromboresistance: the role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells.
    Curwen KD; Gimbrone MA; Handin RI
    Lab Invest; 1980 Mar; 42(3):366-74. PubMed ID: 6244462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.
    Hamid S; Whittle BJ
    Br J Pharmacol; 1985 May; 85(1):285-90. PubMed ID: 2992652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
    Bussolino F; Camussi G
    Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendothelium.
    Weiss HJ; Turitto VT
    Blood; 1979 Feb; 53(2):244-50. PubMed ID: 367465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
    Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.